Reply:
Zigmund Luka, M. Luz Martínez‐Chantar, Shelly C. Lu, Conrad Wager, José M. Mato – 28 May 2009
Activation of the cholehepatic shunt as a potential therapy for primary sclerosing cholangitis
Shannon S. Glaser, Gianfranco Alpini – 28 May 2009
Long‐term outcome of hepatitis B e antigen–negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time
Dar‐In Tai, Shi‐Ming Lin, I‐Shyan Sheen, Chia‐Ming Chu, Deng‐Yn Lin, Yun‐Fan Liaw – 28 May 2009 – The baseline alanine aminotransferase (ALT) level was reported to have prognostic value in chronic hepatitis B virus (HBV) infection, during which ALT may change over time. Instead of baseline ALT, this study aimed to study the prognostic value of the height of ALT during the course of chronic HBV infection.
Methodological reporting of randomized clinical trials in major gastroenterology and hepatology journals in 2006
Yu Bai, Jun Gao, Duo‐Wu Zou, Zhao‐Shen Li – 28 May 2009 – To determine the current quality of reporting of randomized clinical trials (RCTs) in the field of gastroenterology and hepatology, we evaluated the methodological reporting of RCTs in six major gastroenterology and hepatology journals.
Management of adult patients with ascites due to cirrhosis: An update
Bruce A. Runyon – 28 May 2009
Use of a donor aortic interposition allograft to treat stenosis of the suprahepatic inferior vena cava after liver transplantation
Kourosh Saeb‐Parsy, Asif Jah, Andrew J. Butler, Stephen Large, Gavin J. Pettigrew, Raaj K. Praseedom, Christopher J. Watson, Neville V. Jamieson – 28 May 2009
Living donor liver transplantation using a graft from a donor with situs inversus totalis
Jae Min Chun, Gum O. Jung, Gyu Seong Choi, Jae Berm Park, Choon Hyuck David Kwon, Sung‐Joo Kim, Jae‐Won Joh, Suk‐Koo Lee – 28 May 2009
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2−/− mice
Emina Halilbasic, Romina Fiorotto, Peter Fickert, Hanns‐Ulrich Marschall, Tarek Moustafa, Carlo Spirli, Andrea Fuchsbichler, Judith Gumhold, Dagmar Silbert, Kurt Zatloukal, Cord Langner, Uday Maitra, Helmut Denk, Alan F. Hofmann, Mario Strazzabosco, Michael Trauner – 28 May 2009 – 24‐norursodeoxycholic acid (norUDCA), a side chain–modified ursodeoxycholic acid derivative, has dramatic therapeutic effects in experimental cholestasis and may be a promising agent for the treatment of cholestatic liver diseases.
Intramitochondrial crystalline inclusions in nonalcoholic steatohepatitis
Stephen H. Caldwell, Luiz Antonio R. de Freitas, Sang H. Park, Maria Lucia V. Moreno, Jan A. Redick, Christine A. Davis, Barbee J. Sisson, James T. Patrie, Helma Cotrim, Curtis K. Argo, Abdullah Al‐Osaimi – 28 May 2009 – Mitochondrial dysfunction is an important element in the pathogenesis of nonalcoholic steatohepatitis (NASH). Intramitochondrial crystals (IMCs) are a well‐documented morphological abnormality seen on transmission electron microscopy in this disease.